Maximus (NYSE:MMS) Upgraded by Raymond James to Outperform Rating

Raymond James upgraded shares of Maximus (NYSE:MMS) from a market perform rating to an outperform rating in a report published on Thursday morning, Marketbeat Ratings reports. Raymond James currently has $90.00 target price on the health services provider’s stock.

Separately, StockNews.com cut Maximus from a “buy” rating to a “hold” rating in a report on Friday, December 27th.

Maximus Stock Up 1.6 %

Shares of NYSE:MMS opened at $75.81 on Thursday. Maximus has a 1 year low of $69.72 and a 1 year high of $93.97. The company has a debt-to-equity ratio of 0.59, a current ratio of 1.49 and a quick ratio of 1.49. The business’s 50-day moving average is $77.95 and its 200-day moving average is $85.34. The company has a market capitalization of $4.57 billion, a price-to-earnings ratio of 15.16 and a beta of 0.73.

Maximus Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Saturday, November 30th. Stockholders of record on Friday, November 15th were issued a dividend of $0.30 per share. The ex-dividend date of this dividend was Friday, November 15th. This represents a $1.20 annualized dividend and a dividend yield of 1.58%. Maximus’s dividend payout ratio is currently 24.00%.

Insider Transactions at Maximus

In other Maximus news, Director Raymond B. Ruddy acquired 3,490 shares of Maximus stock in a transaction dated Thursday, December 12th. The stock was purchased at an average cost of $71.46 per share, for a total transaction of $249,395.40. Following the completion of the acquisition, the director now directly owns 112,520 shares of the company’s stock, valued at $8,040,679.20. This represents a 3.20 % increase in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, insider Michelle F. Link sold 2,208 shares of the business’s stock in a transaction dated Tuesday, December 3rd. The stock was sold at an average price of $73.83, for a total transaction of $163,016.64. Following the sale, the insider now directly owns 6,567 shares of the company’s stock, valued at approximately $484,841.61. The trade was a 25.16 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have purchased 7,063 shares of company stock valued at $502,017 in the last 90 days. 1.40% of the stock is currently owned by corporate insiders.

Hedge Funds Weigh In On Maximus

Hedge funds have recently added to or reduced their stakes in the stock. Raymond James & Associates boosted its position in shares of Maximus by 9.6% during the second quarter. Raymond James & Associates now owns 14,516 shares of the health services provider’s stock valued at $1,244,000 after buying an additional 1,275 shares during the last quarter. Archer Investment Corp boosted its holdings in Maximus by 8,788.9% during the 2nd quarter. Archer Investment Corp now owns 800 shares of the health services provider’s stock worth $69,000 after acquiring an additional 791 shares during the last quarter. Arizona State Retirement System boosted its holdings in Maximus by 1.9% during the 2nd quarter. Arizona State Retirement System now owns 17,086 shares of the health services provider’s stock worth $1,464,000 after acquiring an additional 322 shares during the last quarter. Foundry Partners LLC bought a new stake in shares of Maximus in the 2nd quarter worth $4,315,000. Finally, Los Angeles Capital Management LLC raised its holdings in shares of Maximus by 148.0% in the second quarter. Los Angeles Capital Management LLC now owns 16,068 shares of the health services provider’s stock valued at $1,377,000 after purchasing an additional 9,590 shares during the last quarter. Institutional investors and hedge funds own 97.21% of the company’s stock.

Maximus Company Profile

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.